GLP-1 receptor agonist

Concept

Class of drugs that mimic glucagon-like peptide-1 hormone to treat diabetes and obesity

7 stories

GLP-1 Drugs Show Health Benefits for Patients Who Do Not Lose Weight

Researchers Identify Genetic Variants That Influence How Well Obesity Drugs Work

FDA Approves Eli Lilly's Oral Weight-Loss Drug, Entering Market Against Novo Nordisk

FDA Approves Higher-Dose Wegovy for Weight Loss Treatment

Wegovy Users Face Five Times Greater Risk of Sudden Sight Loss Than Ozempic Users

Two Deaths Reported to Regulators Potentially Linked to Weight-Loss Injections

GLP-1 Weight-Loss Drugs Linked to Bone and Tendon Injuries